Anti-ErbB2 mAb H2-18 induces PCD in ErbB2-overexpresing breast cancer cells.
H2-18 plus saracatinib induce a greater PCD compared with either drug alone.
H2-18 and saracatinib synergistically inhibit in vitro cell proliferation of breast cancer cells.
H2-18 plus saracatinib exert a greater in vivo antitumor activity than either drug alone.
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址:北京市海淀区学院路29号 邮编:100083 电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700 |